RUBY - Rubius Therapeutics EPS beats by $0.08 March, 12 2020 07:10 AM Rubius Therapeutics Inc. Rubius Therapeutics (NASDAQ:RUBY): Q4 GAAP EPS of -$0.56 beats by $0.08.Cash, cash equivalents and investments of $283.29MPress ReleaseMore news on: Rubius Therapeutics, Inc., Earnings news and commentary, Healthcare stocks news,